IL154962A0 - Potassium channel interactors and uses therefor - Google Patents
Potassium channel interactors and uses thereforInfo
- Publication number
- IL154962A0 IL154962A0 IL15496201A IL15496201A IL154962A0 IL 154962 A0 IL154962 A0 IL 154962A0 IL 15496201 A IL15496201 A IL 15496201A IL 15496201 A IL15496201 A IL 15496201A IL 154962 A0 IL154962 A0 IL 154962A0
- Authority
- IL
- Israel
- Prior art keywords
- potassium channel
- uses therefor
- channel interactors
- interactors
- therefor
- Prior art date
Links
- 102000004257 Potassium Channel Human genes 0.000 title 1
- 108020001213 potassium channel Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Neurosurgery (AREA)
- Biophysics (AREA)
- Neurology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Plant Pathology (AREA)
- Toxicology (AREA)
- Cardiology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/670,756 US7078481B1 (en) | 1998-11-20 | 2000-09-27 | Potassium channel interactors and uses therefor |
US09/703,094 US7556938B1 (en) | 1998-11-20 | 2000-10-31 | Nucleic acids encoding potassium channel interactors |
PCT/US2001/030463 WO2002026984A2 (fr) | 2000-09-27 | 2001-09-27 | Proteines d'interaction de canaux potassiques (pcip) et leurs procedes d'utilisation |
Publications (1)
Publication Number | Publication Date |
---|---|
IL154962A0 true IL154962A0 (en) | 2003-10-31 |
Family
ID=27100393
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL15496201A IL154962A0 (en) | 2000-09-27 | 2001-09-27 | Potassium channel interactors and uses therefor |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1322759A2 (fr) |
JP (1) | JP2004525610A (fr) |
KR (1) | KR20030074604A (fr) |
CN (1) | CN1498271A (fr) |
AU (1) | AU2001296393A1 (fr) |
BR (1) | BR0114383A (fr) |
CA (1) | CA2420960A1 (fr) |
CZ (1) | CZ20031154A3 (fr) |
EA (1) | EA200300420A1 (fr) |
IL (1) | IL154962A0 (fr) |
MX (1) | MXPA03002557A (fr) |
NO (1) | NO20031369L (fr) |
WO (1) | WO2002026984A2 (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7067312B1 (en) | 2001-09-19 | 2006-06-27 | Myriad Genetics, Inc. | PN7718 nucleic acids and use thereof |
WO2004041193A2 (fr) * | 2002-11-01 | 2004-05-21 | Decode Genetics Ehf. | Diabete humain de type ii: voie du gene kv-proteine d'interaction (kchip1) situes sur le chromosome 5 |
EP2353014A2 (fr) * | 2008-11-06 | 2011-08-10 | Basf Se | Test de criblage ea pour insecticides |
CN105483276B (zh) * | 2016-02-01 | 2019-06-11 | 成都望路医药技术有限公司 | Kcnip4基因及其表达产物在直肠腺癌诊疗中的应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU4758997A (en) * | 1996-10-17 | 1998-05-11 | Nps Pharmaceuticals, Inc. | Potassium channel blocking compounds and their use |
US6117989A (en) * | 1998-03-26 | 2000-09-12 | Incyte Pharmaceuticals, Inc. | Human calcium-binding proteins |
MXPA01004903A (es) * | 1998-11-20 | 2003-03-10 | Millennium Pharm Inc | Agentes que interactuan con canales del potasio y usos de los mismos. |
AU5151100A (en) * | 1999-05-19 | 2000-12-05 | Incyte Genomics, Inc. | Extracellular signaling molecules |
WO2001053312A1 (fr) * | 1999-12-23 | 2001-07-26 | Hyseq, Inc. | Nouveaux acides nucleiques et polypeptides |
-
2001
- 2001-09-27 BR BR0114383-2A patent/BR0114383A/pt not_active IP Right Cessation
- 2001-09-27 EP EP01977260A patent/EP1322759A2/fr not_active Withdrawn
- 2001-09-27 CN CNA018191681A patent/CN1498271A/zh active Pending
- 2001-09-27 IL IL15496201A patent/IL154962A0/xx unknown
- 2001-09-27 WO PCT/US2001/030463 patent/WO2002026984A2/fr not_active Application Discontinuation
- 2001-09-27 EA EA200300420A patent/EA200300420A1/ru unknown
- 2001-09-27 AU AU2001296393A patent/AU2001296393A1/en not_active Abandoned
- 2001-09-27 CZ CZ20031154A patent/CZ20031154A3/cs unknown
- 2001-09-27 CA CA002420960A patent/CA2420960A1/fr not_active Abandoned
- 2001-09-27 JP JP2002530747A patent/JP2004525610A/ja active Pending
- 2001-09-27 MX MXPA03002557A patent/MXPA03002557A/es unknown
- 2001-09-27 KR KR10-2003-7004460A patent/KR20030074604A/ko not_active Application Discontinuation
-
2003
- 2003-03-26 NO NO20031369A patent/NO20031369L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1322759A2 (fr) | 2003-07-02 |
BR0114383A (pt) | 2005-04-12 |
CA2420960A1 (fr) | 2002-04-04 |
JP2004525610A (ja) | 2004-08-26 |
NO20031369D0 (no) | 2003-03-26 |
MXPA03002557A (es) | 2004-09-10 |
NO20031369L (no) | 2003-05-22 |
KR20030074604A (ko) | 2003-09-19 |
WO2002026984A3 (fr) | 2003-03-13 |
CZ20031154A3 (cs) | 2003-09-17 |
EA200300420A1 (ru) | 2004-04-29 |
CN1498271A (zh) | 2004-05-19 |
AU2001296393A1 (en) | 2002-04-08 |
WO2002026984A2 (fr) | 2002-04-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EG23122A (en) | Pyrrolcarboxamides and pyrrolcarbothioamides | |
AU9667901A (en) | Mycoattractants and mycopesticides | |
GB0022613D0 (en) | Graphical user interface | |
AU2001276031A1 (en) | Branded channel | |
GB2372923B (en) | Audio user interface with selective audio field expansion | |
AU2001273569A1 (en) | Perfluoropolyethers and processes therefor and therewith | |
AU5091201A (en) | Vegf-modulated genes and methods employing them | |
GB0006733D0 (en) | Enzyme | |
GB0023004D0 (en) | Improved graphical user interface | |
AU2001292936A1 (en) | Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines | |
GB2367225B (en) | User interface | |
PL360620A1 (en) | User interface | |
AU2001295185A1 (en) | Multiplexing-interleaving and demultiplexing-deinterleaving | |
TWI319003B (en) | Arcelin-5 promoter and uses thereof | |
IL154962A0 (en) | Potassium channel interactors and uses therefor | |
IL143148A0 (en) | Potassium channel interactors and uses therefor | |
AU9233001A (en) | Drying-resistant yeast | |
HK1046914A1 (zh) | 鉀通道互作劑及其用途 | |
EP1347049A4 (fr) | Nouveau canal de potassium | |
EP1347050A4 (fr) | Nouveau canal potassique | |
GB2364412B (en) | Abacus | |
GB0017323D0 (en) | Enzyme | |
GB0116100D0 (en) | Drawing and sketching aid | |
AU2001273888A1 (en) | New sodium channel (rnav1.5a) and use thereof | |
AU144114S (en) | An eraser |